Pharma Journalist 7836 posts 0 comments

Epizyme has earned a $10 million milestone payment from GlaxoSmithKline (GSK) to follow GSK's initiation of GLP toxicology studies for a first-in-class methyltransferase inhibitor…
Read More...

Corvus Pharmaceuticals has expanded its clinical collaboration with Genentech. Under the new agreement, CPI-444 administered in combination with atezolizumab (Tecentriq) will be…
Read More...

Provista appoints Jim Cunniff as new president and CEO who will succeed Dan Thomas. He assumed his new role with Provista on May 1, 2017. Prior to joining Provista, Cunniff was the…
Read More...

Quivive has entered into service agreements with Camargo Pharmaceutical Services. Camargo will be providing regulatory consulting and strategic development services for Quivive's…
Read More...

SGS announced the successful completion of a Phase I clinical trial of a new strain of influenza virus in healthy volunteers. The study used a GMP-manufactured, non-hemagglutinating,…
Read More...

Sorrento Therapeutics  announced that Levena has completed construction and put into operation a 25,000 square foot GMP (Good Manufacturing Practice) manufacturing facility in Suzhou,…
Read More...

Alcami Corporation announced an investment of  $5 million in the expansion of its existing Charleston County operations. Alcami offers a variety of biopharmaceutical services across…
Read More...

Dragonfly Therapeutics announced that they have appointed Dr. Asya Grinberg to its senior team as Head of Biologics. Dr. Grinberg spent 12 years at Acceleron Pharma discovering…
Read More...

Vivet Therapeutics announced that it has recieved €37.5 million in a Series A financing round for advancement in developing gene therapies for treatment of rare inherited metabolic…
Read More...

BioPharmX announced that it achieved primary endpoint in its phase 2b clinical trial evaluating BPX-011. From the topline results for the study's primary endpoint, BioPharmX…
Read More...